MedPath

To observe the effect of unani medicine in patients having little flow during periods.

Phase 2
Conditions
Health Condition 1: N915- Oligomenorrhea, unspecifiedHealth Condition 2: null- Oligomenorrhoea
Registration Number
CTRI/2018/02/012193
Lead Sponsor
ational Institute Of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Infrequent menstruation of more than 35days or scanty flow both in amount and duration,

Hypothyroidism on treatment & PCOD.

Exclusion Criteria

Patients with hyperprolactinaemia,Uterine synechiae, endometrial tuberculosis, ovarian tumours & malignancy,Hypertension, Diabetes mellitus & other systemic diseases,Pregnant women, lactating women and women on IUCDs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath